
Hovione Opens New Facility, Doubling US Spray Drying Capacity
Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.

Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.

The investment will reinforce the Bend site as a center of excellence for particle engineering and bioavailability enhancement and create a global manufacturing hub for commercial spray-drying.

Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.

Lisbon, Portugal-headquartered Hovione has completed significant expansions in Europe and the USA. The investments at the facilities in East Windsor, New Jersey, and Ringaskiddy, Cork, significantly increase the global capacities of the CDMO (contract development and manufacturing organization) for spray drying for pharma applications and improve the sites' capabilities.

